已发表论文

对一例复发性卵巢室管膜瘤的个性化治疗

 

Authors Yuan Z, Yu M, Chen Y

Received 15 July 2018

Accepted for publication 29 November 2018

Published 20 December 2018 Volume 2019:12 Pages 113—117

DOI https://doi.org/10.2147/OTT.S180309

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Dr Sanjay Singh

Abstract: Ovarian anaplastic ependymoma is a rare gynecologic malignancy. Owing to its rarity, treatment is challenging. Unilateral ovarian ependymoma was found during laparoscopy in a 19-year-old woman. After cytoreductive surgery, three cycles of bleomycin, etoposide, and cisplatin were administered. Four years after chemotherapy, the patient experienced relapse. After the secondary cytoreductive surgery, no further treatment was performed. She is in good condition, ~19 months after secondary cytoreductive surgery using hormone-replacement therapy without chemotherapy. Some cases of ovarian ependymoma can be treated with surgery alone without chemotherapy and the outcome has been satisfying. Choosing treatment based on malignant ovarian germ cell tumors may be not optimal. Therefore, we suggest individualized treatment for ovarian ependymoma.
Keywords: ovarian ependymoma, contralateral ovary, chemotherapy, hormone-based treatment




Figure 1 PET/CT scan revealing multiple hypermetabolic cystic and solid masses ahead of the rectum.